These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30023569)

  • 1. Cancer Therapeutic Proficiency of Dual-Targeted Mesoporous Silica Nanocomposite Endorses Combination Drug Delivery.
    Murugan C; Venkatesan S; Kannan S
    ACS Omega; 2017 Nov; 2(11):7959-7975. PubMed ID: 30023569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial nanocarrier based drug delivery approach for amalgamation of anti-tumor agents in breast cancer cells: an improved nanomedicine strategy.
    Murugan C; Rayappan K; Thangam R; Bhanumathi R; Shanthi K; Vivek R; Thirumurugan R; Bhattacharyya A; Sivasubramanian S; Gunasekaran P; Kannan S
    Sci Rep; 2016 Oct; 6():34053. PubMed ID: 27725731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aerosol technique-based carbon-encapsulated hollow mesoporous silica nanoparticles for synergistic chemo-photothermal therapy.
    Gautam M; Thapa RK; Poudel BK; Gupta B; Ruttala HB; Nguyen HT; Soe ZC; Ou W; Poudel K; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2019 Apr; 88():448-461. PubMed ID: 30818051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH-Sensitive Drug Delivery System Based on Mesoporous Silica Modified with Poly-L-Lysine (PLL) as a Gatekeeper.
    Lee NK; Park SS; Ha CS
    J Nanosci Nanotechnol; 2020 Nov; 20(11):6925-6934. PubMed ID: 32604538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles.
    Pan L; He Q; Liu J; Chen Y; Ma M; Zhang L; Shi J
    J Am Chem Soc; 2012 Apr; 134(13):5722-5. PubMed ID: 22420312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Charge-reversal plug gate nanovalves on peptide-functionalized mesoporous silica nanoparticles for targeted drug delivery.
    Luo GF; Chen WH; Liu Y; Zhang J; Cheng SX; Zhuo RX; Zhang XZ
    J Mater Chem B; 2013 Nov; 1(41):5723-5732. PubMed ID: 32261195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-responsive poly (acrylic acid)-gated mesoporous silica and its application in oral colon targeted drug delivery for doxorubicin.
    Tian B; Liu S; Wu S; Lu W; Wang D; Jin L; Hu B; Li K; Wang Z; Quan Z
    Colloids Surf B Biointerfaces; 2017 Jun; 154():287-296. PubMed ID: 28351801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme-induced and tumor-targeted drug delivery system based on multifunctional mesoporous silica nanoparticles.
    Cheng YJ; Luo GF; Zhu JY; Xu XD; Zeng X; Cheng DB; Li YM; Wu Y; Zhang XZ; Zhuo RX; He F
    ACS Appl Mater Interfaces; 2015 May; 7(17):9078-87. PubMed ID: 25893819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synchronized Ratiometric Codelivery of Metformin and Topotecan through Engineered Nanocarrier Facilitates In Vivo Synergistic Precision Levels at Tumor Site.
    Banala VT; Sharma S; Barnwal P; Urandur S; Shukla RP; Ahmad N; Mittapelly N; Pandey G; Dwivedi M; Kalleti N; Mitra K; Rath SK; Trivedi R; Mishra PR
    Adv Healthc Mater; 2018 Oct; 7(19):e1800300. PubMed ID: 30102470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional Peptide-Amphiphile End-Capped Mesoporous Silica Nanoparticles for Tumor Targeting Drug Delivery.
    Cheng YJ; Zhang AQ; Hu JJ; He F; Zeng X; Zhang XZ
    ACS Appl Mater Interfaces; 2017 Jan; 9(3):2093-2103. PubMed ID: 28032742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary nuclear targeting of mesoporous silica nano-particles for cancer-specific drug delivery based on charge inversion.
    Zhao J; Zhao F; Wang X; Fan X; Wu G
    Oncotarget; 2016 Oct; 7(43):70100-70112. PubMed ID: 27661121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cu
    Zhang Y; Lou J; Williams GR; Ye Y; Ren D; Shi A; Wu J; Chen W; Zhu LM
    Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix Metalloproteinase-Responsive Mesoporous Silica Nanoparticles Cloaked with Cleavable Protein for "Self-Actuating" On-Demand Controlled Drug Delivery for Cancer Therapy.
    Vaghasiya K; Ray E; Sharma A; Katare OP; Verma RK
    ACS Appl Bio Mater; 2020 Aug; 3(8):4987-4999. PubMed ID: 35021676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual pH-responsive mesoporous silica nanoparticles for efficient combination of chemotherapy and photodynamic therapy.
    Yao X; Chen X; He C; Chen L; Chen X
    J Mater Chem B; 2015 Jun; 3(23):4707-4714. PubMed ID: 32262486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide.
    Saroj S; Rajput SJ
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1198-1211. PubMed ID: 29412022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesoporous Silica Nanoparticles Coated by Layer-by-Layer Self-assembly Using Cucurbit[7]uril for in Vitro and in Vivo Anticancer Drug Release.
    Li QL; Sun Y; Sun YL; Wen J; Zhou Y; Bing QM; Isaacs LD; Jin Y; Gao H; Yang YW
    Chem Mater; 2014 Nov; 26(22):6418-6431. PubMed ID: 25620848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. pH-triggered sustained release of arsenic trioxide by polyacrylic acid capped mesoporous silica nanoparticles for solid tumor treatment in vitro and in vivo.
    Xiao X; Liu Y; Guo M; Fei W; Zheng H; Zhang R; Zhang Y; Wei Y; Zheng G; Li F
    J Biomater Appl; 2016 Jul; 31(1):23-35. PubMed ID: 27059495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent carbon dot modified mesoporous silica nanocarriers for redox-responsive controlled drug delivery and bioimaging.
    Jiao J; Liu C; Li X; Liu J; Di D; Zhang Y; Zhao Q; Wang S
    J Colloid Interface Sci; 2016 Dec; 483():343-352. PubMed ID: 27569517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking.
    Chan MH; Lin HM
    Biomaterials; 2015 Apr; 46():149-58. PubMed ID: 25678124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.